TABLE 2.
Cluster/group | ||||||
---|---|---|---|---|---|---|
0 No response (n = 18) | 1 Fast modulation (n = 15) | 2 Slow modulation (n = 23) | 3 Rise to sustained (n = 16) | 4 Sustained (n = 16) | All (n = 88) | |
Age (years, mean) | 43.94 | 44.87 | 40.17 | 37.13 | 39.69 | 41.10 |
ESRF (years, mean) | 13.08 | 7.33 | 10.65 | 12.16 | 14.23 | 11.48 |
Female (%) | 55.56 | 93.33 | 78.26 | 31.25 | 43.75 | 61.36 |
LDKT (%) | 94.44 | 100 | 95.65 | 93.75 | 75 | 92.05 |
Previous tx (%) | 72.22 | 26.67 | 60.87 | 81.25 | 75 | 63.64 |
Crossmatch+ (%) | 55.56 | 73.33 | 69.57 | 93.75 | 81.25 | 73.86 |
CDC+ (%) | 11.11 | 13.33 | 17.39 | 37.5 | 25 | 20.45 |
Out of all CDC+, CDC>1:2 (%) | 0 | 0 | 0 | 100 | 50 | 55.56 |
Pre Tx-DFPP(%) | 66.7 | 80.0 | 82.6 | 93.7 | 62.5 | 77.27 |
Average tDSA value | 2062 | 7023 | 7105 | 14813 | 12674 | 8735 |
DSA (n) | 2 | 3 | 3 | 3 | 3 | 3 |
Rejection within first 30-days, % | 16.67 | 80.0 | 56.52 | 56.25 | 18.75 | 47.73 |
Post Tx-DFPP (%) | 5.56 | 33.33 | 13.04 | 18.75 | 6.25 | 14.77 |
Lymphocyte-depleting agent (%) | 5.56 | 40 | 47.83 | 50 | 12.5 | 31.82 |
GF-5 years (%) | 11.11 | 6.67 | 4.35 | 31.25 | 25 | 14.77 |
ESRF, end stage renal failure; LDKT, living donor kidney transplant; Tx, transplant; DFPP, double filtration plasmapheresis; CDC, Complement dependent cytoxicity.